Evidence map›Paper›PMID 28886727›Full record

ArticleBMC research notes2017

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso.

Mariama K Cherif, Oumarou Ouédraogo, Guillaume S Sanou, Amidou Diarra, Alphonse Ouédraogo, Alfred Tiono, David R Cavanagh, Theisen Michael, Amadou T Konaté, Nora L Watson and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Genetic Diversity and Allelic Distribution ofJournal of parasitology research · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Mariama K CherifCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Oumarou OuédraogoCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Guillaume S SanouCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Amidou DiarraCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Alphonse OuédraogoCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Alfred TionoCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
David R CavanaghInstitute of Immunology and Infection Research, University of Edinburgh, Scotland, UK.
Theisen MichaelDepartment of Clinical Biochemistry Statens Serum, Copenhagen, Denmark.
Amadou T KonatéCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Nora L WatsonThe EMMES Corporation, Rockville, MD, USA.
Megan SanzaThe EMMES Corporation, Rockville, MD, USA.
Tina J T DubeThe EMMES Corporation, Rockville, MD, USA.
Sodiomon B SirimaCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Issa NebiéCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso. issanebie.cnlp@fasonet.bf.
Centre National de Recherche et de Formation sur le Paludisme · BFEmmes (United States) · USNazi Boni University · BFStatens Serum Institut · DKUniversité Joseph Ki-Zerbo · BFUniversity of Edinburgh · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh parasite-specific antibody levels are generally associated with low susceptibility to Plasmodium falciparum malaria. This has been supported by several studies in which clinical malaria cases of P. falciparum malaria were reported to be associated with low antibody avidities. This study was conducted to evaluate the role of age, malaria transmission intensity and incidence of clinical malaria in the induction of protective humoral immune response against P. falciparum malaria in children living in Burkina Faso.

methodsWe combined levels of IgG and IgG subclasses responses to P. falciparum antigens: Merozoite Surface Protein 3 (MSP3), Merozoite Surface Protein 2a (MSP2a), Merozoite Surface Protein 2b (MSP2b), Glutamate Rich Protein R0 (GLURP R0) and Glutamate Rich Protein R2 (GLURP R2) in plasma samples from 325 children under five (05) years with age, malaria transmission season and malaria incidence.

resultsWe notice higher prevalence of P. falciparum infection in low transmission season compared to high malaria transmission season. While, parasite density was lower in low transmission than high transmission season. IgG against all antigens investigated increased with age. High levels of IgG and IgG subclasses to all tested antigens except for GLURP R2 were associated with the intensity of malaria transmission. IgG to MSP3, MSP2b, GLURP R2 and GLURP R0 were associated with low incidence of malaria. All IgG subclasses were associated with low incidence of P. falciparum malaria, but these associations were stronger for cytophilic IgGs.

conclusionsOn the basis of the data presented in this study, we conclude that the induction of humoral immune response to tested malaria antigens is related to age, transmission season level and incidence of clinical malaria.

Indexed as

AdolescentAge FactorsAntibodies, ProtozoanAntibody FormationAntigens, ProtozoanBurkina FasoChildChild, PreschoolFemaleHumansIncidenceInfantMalaria, FalciparumMalePlasmodium falciparumAntibodies, ProtozoanAntigens, ProtozoanAgeAntigensMalaria transmission sessionsP. falciparum infection

Identifiers

PMID28886727
PMCPMC5591548
OpenAlexW2754368978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.